Search Results

TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model.

• Authors : Schober, Sebastian J.; Thiede, Melanie; Gassmann, Hendrik

Subjects: ONCOLYTIC virotherapy; EWING'S sarcoma; T cells

• Source: Frontiers in Immunology; 2024, p1-14, 14p

Record details

Hypothesis: AdAPT-001 and pseudoprogression - when seeing is not necessarily believing.

• Authors : Conley A; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Larson C

Subjects: Disease Progression* ; Oncolytic Virotherapy*/Oncolytic Virotherapy*/Oncolytic Virotherapy*/methods; Humans

• Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jun 17; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 17.Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Intravesical oncolytic virotherapy and immunotherapy for non‐muscle‐invasive bladder cancer mouse model.

• Authors : Smelser, Woodson W.; Wang, Jian; Ogden, Kristen M.

Subjects: UROTHELIUM; ONCOLYTIC virotherapy; CANCER invasiveness

• Source: BJU International; Sep2023, Vol. 132 Issue 3, p298-306, 9p

Record details

Oncolytic adenovirus treatment induces the reduction of tumor dimension in a model of mice lung adenocarcinoma multicellular spheroids.

• Authors : Vitale, Maria; Scialò, Filippo; Patriciello, Teresa

Subjects: ONCOLYTIC virotherapy; LUNG cancer; ADENOCARCINOMA

• Source: Biochimica Clinica; set2023, Vol. 47 Issue 3, p251-258, 8p

Record details

Editorial: Recent advances in oncolytic virus therapy for brain tumors.

• Authors : Askari, Fatemeh Sana; Mohebbi, Alireza; Ning, Jianfang

Subjects: ONCOLYTIC virotherapy; BRAIN tumors; REGULATORY T cells

• Source: Frontiers in Cellular & Infection Microbiology; 2023, p1-3, 3p

Record details

Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies.

• Authors : Tripodi, Lorella; Sasso, Emanuele; Feola, Sara

Subjects: VIRAL antigens; VIRUSES; CELL physiology

• Source: Cancers; Feb2023, Vol. 15 Issue 4, p1297, 20p

Record details

Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells.

• Authors : Davola, Maria Eugenia; Cormier, Olga; Vito, Alyssa

Subjects: CANCER chemotherapy; ANIMAL experimentation; ANTINEOPLASTIC agents

• Source: Cancers; Feb2023, Vol. 15 Issue 4, p1295, 18p

Record details

Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model.

• Authors : Vitale, Maria; Scialò, Filippo; Passariello, Margherita

Subjects: ONCOLYTIC virotherapy; LABORATORY mice; IMMUNE checkpoint inhibitors

• Source: Frontiers in Oncology; 5/20/2022, Vol. 12, p1-12, 12p

Record details

Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model.

• Authors : Kasten, Benjamin B.; Houson, Hailey A.; Coleman, Jennifer M.

Subjects: POSITRON emission tomography; CD8 antigen; GLIOMAS

• Source: Scientific Reports; 7/28/2021, Vol. 11 Issue 1, p1-12, 12p

Record details

New Findings in Oncolytic Virotherapy Described from University of Pittsburgh (An Oncolytic Virus-delivered Tgfb Inhibitor Overcomes the Immunosuppressive Tumor Microenvironment).

Subjects: ONCOLYTIC virotherapy; TUMOR microenvironment; VACCINIAUNIVERSITY of Pittsburgh

• Source: Cancer Gene Therapy Week; 12/4/2023, p31-31, 1p

Record details